Article info

Lixisenatide is effective and safe as add-on treatment to basal insulin in Asian individuals with type 2 diabetes and different body mass indices: a pooled analysis of data from the GetGoal Studies

Authors

  1. Correspondence to Dr Dalong Zhu; zhudalong{at}nju.edu.cn
View Full Text

Citation

Feng W, Wang W, Meng R, et al
Lixisenatide is effective and safe as add-on treatment to basal insulin in Asian individuals with type 2 diabetes and different body mass indices: a pooled analysis of data from the GetGoal Studies

Publication history

  • Received March 23, 2021
  • Accepted July 17, 2021
  • First published August 27, 2021.
Online issue publication 
August 27, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.